Concepedia

Publication | Closed Access

Nationwide Study on Hypertrophic Cardiomyopathy in Iceland

DOI

66

Citations

34

References

2014

Year

Berglind Aðalsteinsdóttir, Polakit Teekakirikul, Barry J. Maron, Michael A. Burke, Daníel F. Guðbjartsson, Hilma Hólm, Kāri Stefánsson, Steven R. DePalma, Erica Mazaika, Barbara McDonough,
Circulation

Abstract

A founder MYBPC3 mutation that arose >550 years ago is the predominant cause of HCM in Iceland. The MYBPC3 c.927-2A>G mutation is associated with low adverse event rates but earlier cardiovascular mortality, illustrating the impact of genotype on outcomes in HCM.

References

YearCitations

Page 1